Paul R. Fonteyne Apellis Pharmaceuticals, Inc. (APLS) insider trading activity
Paul R. Fonteyne is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 16,438 shares of APLS, which is worth approximately $505,797. The most recent transaction as insider was on Jan 01, 2024, when has been sold 3,341 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
16.4K
0%
3M change
25.51%
12M change
Total Value Held
$505,797
PAUL R. FONTEYNE Transaction History
Also insider at
PRF
Paul R. Fonteyne
Director
Portland, ME